JP2024541472A5 - - Google Patents

Info

Publication number
JP2024541472A5
JP2024541472A5 JP2024530570A JP2024530570A JP2024541472A5 JP 2024541472 A5 JP2024541472 A5 JP 2024541472A5 JP 2024530570 A JP2024530570 A JP 2024530570A JP 2024530570 A JP2024530570 A JP 2024530570A JP 2024541472 A5 JP2024541472 A5 JP 2024541472A5
Authority
JP
Japan
Application number
JP2024530570A
Other languages
Japanese (ja)
Other versions
JPWO2023097259A5 (https=
JP2024541472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/080408 external-priority patent/WO2023097259A1/en
Publication of JP2024541472A publication Critical patent/JP2024541472A/ja
Publication of JP2024541472A5 publication Critical patent/JP2024541472A5/ja
Publication of JPWO2023097259A5 publication Critical patent/JPWO2023097259A5/ja
Pending legal-status Critical Current

Links

JP2024530570A 2021-11-23 2022-11-23 がん治療のためにRARγアゴニストを使用する方法 Pending JP2024541472A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163282547P 2021-11-23 2021-11-23
US63/282,547 2021-11-23
PCT/US2022/080408 WO2023097259A1 (en) 2021-11-23 2022-11-23 METHODS OF USING RARγ AGONISTS FOR CANCER TREATMENT

Publications (3)

Publication Number Publication Date
JP2024541472A JP2024541472A (ja) 2024-11-08
JP2024541472A5 true JP2024541472A5 (https=) 2025-12-08
JPWO2023097259A5 JPWO2023097259A5 (https=) 2025-12-08

Family

ID=85706524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024530570A Pending JP2024541472A (ja) 2021-11-23 2022-11-23 がん治療のためにRARγアゴニストを使用する方法

Country Status (11)

Country Link
US (3) US11793835B2 (https=)
EP (1) EP4436574A4 (https=)
JP (1) JP2024541472A (https=)
KR (1) KR20240111779A (https=)
CN (1) CN118574611A (https=)
AU (1) AU2022398628A1 (https=)
CA (1) CA3239689A1 (https=)
CL (1) CL2024001542A1 (https=)
IL (1) IL313052A (https=)
MX (1) MX2024006212A (https=)
WO (1) WO2023097259A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11976021B2 (en) 2022-06-27 2024-05-07 Io Therapeutics, Inc. Synthesis of tetrahydronaphthalenols and uses thereof
WO2025240479A1 (en) * 2024-05-14 2025-11-20 Children's National Medical Center Trained tumor specific t-cell for immunotherapy and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
DE60136477D1 (de) * 2000-10-02 2008-12-18 Hoffmann La Roche Retinoide zur behandlung von emphysem
WO2005046726A2 (en) * 2003-11-12 2005-05-26 Allergan, Inc. Combinations for inhibiting cell growth which contains an inhibitor of human ck1 alpha activity and a rxr agonist
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
BRPI0616454A2 (pt) 2005-09-30 2011-06-21 Vitae Pharmaceuticals, Inc. métodos de tratamento de cáncer
US20070185055A1 (en) 2006-02-06 2007-08-09 Guang Liang Jiang Method for treating cachexia with retinoid ligands
SG11201810951RA (en) * 2016-06-10 2019-01-30 Io Therapeutics Inc Receptor selective retinoid and rexinoid compounds and immune modulators for cancer immunotherapy
KR20200029544A (ko) * 2017-07-13 2020-03-18 아이오 테라퓨틱스, 인크. 암 면역요법을 위해 면역 조절제와 조합된 면역조절 레티노이드 및 렉시노이드 화합물
US10966950B2 (en) 2019-06-11 2021-04-06 Io Therapeutics, Inc. Use of an RXR agonist in treating HER2+ cancers

Similar Documents

Publication Publication Date Title
JP2024541472A5 (https=)
BR102022025291A2 (https=)
CL2026000082A1 (es) Método y disposición para predecir cod en un proceso de tratamiento de aguas residuales.
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
CN307047624S (https=)
BY13167U (https=)
BY13156U (https=)
BY13155U (https=)
BY13153U (https=)
BY13152U (https=)
BY13151U (https=)
BY13150U (https=)
CN307049483S (https=)
CN307048851S (https=)
CN307048734S (https=)
BY13158U (https=)
CN307048515S (https=)
BY23963C1 (https=)